Pictet Asset Management
WVE icon

Pictet Asset Management’s Wave Life Sciences WVE Stock Holding History

Pictet Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.2M Buy
1,149,127
+343,226
+43% +$4.47M 0.01% 690
2025
Q4 		$13.8M Buy
805,901
+790,175
+5,025% +$8.03M 0.01% 601
2025
Q3 		$115K Sell
15,726
-653
-4% -$5.28K ﹤0.01% 1968
2025
Q2 		$107K Buy
16,379
+4,102
+33% +$27.1K ﹤0.01% 1926
2025
Q1 		$99.2K Sell
12,277
-3,302
-21% -$36.1K ﹤0.01% 1931
2024
Q4 		$193K Buy
15,579
+4,120
+36% +$55K ﹤0.01% 1862
2024
Q3 		$94K Hold
11,459
– – ﹤0.01% 1947
2024
Q2 		$57.2K Buy
+11,459
New +$65.4K ﹤0.01% 1937

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pictet Asset Management's WVE Position: Q1 2026 in Review

Pictet Asset Management increased its Wave Life Sciences (WVE) stake by 43% in Q1 2026, buying an estimated $4.47M and bringing the position to 1,149,127 shares worth $8.2M. The position accounts for 0.01% of the portfolio, ranked #690.

Pictet Asset Management first reported a position in WVE in Q2 2024 and has held it in 8 quarters since. The position peaked at $13.8M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Pictet Asset Management held 1,149,127 shares of Wave Life Sciences worth $8.2M as of Q1 2026.
  • Pictet Asset Management bought 343,226 Wave Life Sciences shares in Q1 2026, an estimated $4.47M.
  • Wave Life Sciences made up 0.01% of Pictet Asset Management's portfolio in Q1 2026, its #690 holding.
  • Pictet Asset Management first reported a position in Wave Life Sciences in Q2 2024 and has held it in 8 quarters since.
  • Pictet Asset Management's Wave Life Sciences position peaked at $13.8M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.